Download Files:
Avelumab
SKU
HY-108730-1 mg
Category Inhibitory Antibodies
Tags Cancer; Inflammation/Immunology, Immunology/Inflammation, PD-1/PD-L1
$350 – $3,100
Products Details
Product Description
– Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
Web ID
– HY-108730
Storage Temperature
– Store at 4°C for 2 years, do not freeze
Shipping
– Isolate blue ice and the product with bubble pack to avoid direct contact
Applications
– Cancer-programmed cell death
Molecular Formula
– N/A
References
– [1]Fujii R, et al. Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget. 2016 Jun 7;7(23):33498-511.|[2]Grenga I, et al. A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses. Clin Transl Immunology. 2016 May 20;5(5):e83.|[3]Vandeveer AJ, et al. Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res. 2016 May;4(5):452-62.
CAS Number
– 1537032-82-8
Molecular Weight
– N/A
Compound Purity
– 99.30
SMILES
– [Avelumab]
Clinical Information
– Launched
Research Area
– Cancer; Inflammation/Immunology
Solubility
– H2O
Target
– PD-1/PD-L1
Pathway
– Immunology/Inflammation
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.